About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Wednesday, May 13th, 2015

The QualityStocks
Daily Stock List


Infinity Augmented Reality, Inc. (ALSO)

Money Morning, TopPennyStockMovers, and OTC Markets Group reported on Infinity Augmented Reality, Inc. (ALSO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Infinity Augmented Reality, Inc.’s (InfinityAR) commitment is to creating a new digital environment, which will allow people to naturally interact with augmented content in their physical surroundings. The Company’s technology can transform any device into a strong content augmentation platform, using simple stereoscopic cameras. The Company formerly went by the name Absolute Life Solutions, Inc. It changed its name to Infinity Augmented Reality, Inc. in March 2013.

InfinityAR has received the 2015 Frost & Sullivan Technology Innovation Award. The research group studied the leading AR companies in Europe. InfinityAR received the highest scores on technology attributes and future business value criteria.

InfinityAR’s advanced augmented reality development engine enables accurate 3D digital scene representation of one’s present physical environment, employing the above-mentioned basic, affordable hardware. Any device can be turned into a powerful content augmentation platform, so developers can quickly and easily introduce applications with rich AR experiences to the market.

The Company’s engine surmounts three major challenges in today’s AR environment. These are cost, processing power, as well as battery life. Its engine employs two simple cameras instead of depth sensors, so the cost drops substantially. The use of passive cameras, rather than active infrared sensors, reduces power consumption by 60 percent.

In addition, InfinityAR uses efficient computer vision algorithms that require much less processing power. Moreover, its technology can recognize the user’s gestures for full and natural interaction with the environment. The InfinityAR engine maps the environment exactly. It can also recognize reflective and clear surfaces to make sure the augmented reality objects are seamlessly integrated into the environment.

For application (app) developers, they can use the Infinity AR engine to easily and efficiently develop advanced AR applications and provide a rich AR experience to their users. This can be done with a very natural and intuitive user interface. Infinity Augmented Reality is releasing its beta version in Q3 2015.

Infinity Augmented Reality, Inc. (ALSO), closed Wednesday's trading session at $0.052, up 30.00%, on 192,383 volume with 31 trades. The average volume for the last 60 days is 465,614 and the stock's 52-week low/high is $0.0355/$0.2199.

The MaryJane Group, Inc. (MJMJ)

Penny Stock Bets, Wallstreetlivechat, and Greenbackers reported on The MaryJane Group, Inc. (MJMJ), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

The MaryJane Group, Inc. is the leading hospitality group in the marijuana industry. It has capitalized on the passing of Colorado Amendment 64, through establishing lodging accommodations dedicated to the growing canna-tourism industry. The MaryJane Group lists on the OTC Markets Groups OTCQB. The Company has its headquarters in Denver, Colorado.

The MaryJane Group owns and operates two Bud+Breakfast™ locations, which are its cannabis-friendly lodges in the U.S. It modeled its approach to hospitality after a traditional bed and breakfast. The Company provide clean rooms and comfortable share spaces, as well as gourmet food prepared with fresh ingredients and first-rate customer service.

The MaryJane Group has its “Bud+Breakfast™ at the Adagio” in Denver, Colorado. It is located in an elegant Victorian home in one of Denver’s most historic neighborhoods. The Bud+Breakfast™ at the Adagio is the first, premier cannabis-friendly lodge in Denver. It features six attractively decorated suites, each of them unique and private. The MaryJane Group announced this past March that it signed the contract to purchase The Adagio Bed and Breakfast in Denver. The total purchase price is $1,500,000.

The Company also has its “Bud+Breakfast™ at Mount Vista” in Silverthorne, Colorado. The Bud+Breakfast™ at Mount Vista is a blend of world-class skiing and legal cannabis. This property offers four private suites among two floors. Each floor features a kitchen, dining area, and lounge. The MaryJane Group currently offers cannabis-friendly lodging and events at these two Bud and Breakfast locations.

Recently, The MaryJane Group announced that it reached a preliminary joint venture agreement with the owners of the Wilderness Trail Ranch. This is a 172-acre dude ranch neighboring the San Juan National Forest and within 20 miles of Durango, Colorado. The Company's intention is to transform the dude ranch experience into a "Canna-Camp," through offering guest packages akin to those offered at its existing "Bud and Breakfast" locations in Denver and Silverthorne, Colorado.

Yesterday, The MaryJane Group announced that it has partnered with Botanico, the premier recreational marijuana dispensary in Denver. Botanico offers the highest quality marijuana flower, concentrates, and THC-infused edibles in the city. In addition, Botanico provides a very personal dispensary experience.

The MaryJane Group, Inc. (MJMJ), closed Wednesday's trading session at $0.0145, down 34.09%, on 4,863,797 volume with 201 trades. The average volume for the last 60 days is 464,079 and the stock's 52-week low/high is $0.0039/$11.50.

Soligenix, Inc. (SNGX)

Streetwise Reports and InvestorPlace reported on Soligenix, Inc. (SNGX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Soligenix, Inc. is a late-stage biopharmaceutical company. It is developing products that address unmet medical needs in the areas of inflammation, oncology, and also biodefense. Its proprietary vaccine thermostabilization technology is ThermoVax™.  Soligenix’s areas of focus include a therapeutics segment devoted to the development of products for orphan diseases and areas of unmet medical need including cutaneous T-cell lymphoma, oral mucositis, pediatric Crohn's disease, acute radiation enteritis, and Graft-versus-Host disease (GVHD). Soligenix is based in Princeton, New Jersey.

A second area of focus is a vaccines/biodefense segment to develop vaccines and therapeutics for military and civilian applications in the areas of ricin exposure, anthrax exposure, gastrointestinal acute radiation syndrome, and melioidosis. Soligenix is developing proprietary formulations of oral BDP (beclomethasone 17,21-dipropionate) for the prevention/treatment of gastrointestinal disorders characterized by severe inflammation. This includes pediatric Crohn's disease (SGX203) and acute radiation enteritis (SGX201).

The Company is also advancing its novel innate defense regulator (IDR) technology SGX942 for the treatment of oral mucositis and SGX301, its novel first-in-class photodynamic technology using synthetic hypericin with safe visible light, for the treatment of cutaneous T-cell lymphoma.

Soligenix's biodefense products in development include a recombinant subunit vaccine called RiVax™. The design of it is to protect against the lethal effects of exposure to ricin toxin. It is also developing VeloThrax™, a vaccine against anthrax exposure. In addition, it is developing OrbeShield™ for the treatment of gastrointestinal acute radiation syndrome (GI ARS) under a BARDA (Biomedical Advanced Research and Development Authority) contract award.

Soligenix also has an exclusive global collaboration with Intrexon Corp. (XON). The focus of it is on the joint development of a treatment for Melioidosis, a high priority biothreat and an area of unmet medical need.

Today, Soligenix announced that it initiated a development agreement with Emergent BioSolutions to implement a commercially viable, scalable production technology for the RiVax™ drug substance protein antigen.  Soligenix will transfer the manufacturing processes and analytics to Emergent BioSolutions to conduct process development work that could potentially lead to a future commercial manufacturing collaboration. RiVax™ has been granted orphan drug designation by the Food and Drug Administration (FDA) for the prevention of ricin intoxication.  

Soligenix, Inc.. (SNGX), closed Wednesday's trading session at $1.536, up 5.93%, on 52,018 volume with 64 trades. The average volume for the last 60 days is 141,571 and the stock's 52-week low/high is $0.91/$2.30.

Sabine Oil & Gas Corp. (SOGC)

Today we are highlighting Sabine Oil & Gas Corp. (SOGC), here at the QualityStocks Daily Newsletter.

Sabine Oil & Gas Corp. engages in the acquisition, exploration, development, and exploitation of oil and natural gas properties onshore in the U.S. The Company centers its operations in core geographic regions. These are South Texas, targeting the Eagle Ford Shale formation; East Texas, targeting the Cotton Valley Sand and Haynesville Shale formations; the North Louisiana Haynesville; and North Texas, targeting the Granite Wash formation. Sabine Oil & Gas has its corporate headquarters in Houston, Texas.

In January 2015, Sabine Oil & Gas announced that the OTCQB ticker symbol for the common stock of Sabine was changed from "FSTO" to "SOGC", effective at the open of market trading, January 13, 2015.  Furthermore, the name change from Forest Oil Corp. to Sabine Oil & Gas Corp. was completed and effective December 19, 2014. The combination of Sabine Oil & Gas LLC and Forest Oil Corp. creates one of the largest East Texas positions with concentrated and contiguous acreage.

With the complementary asset positions there is extensive overlap in the top two asset areas, which are East Texas and Eagle Ford. This creates a leading East Texas position of roughly 207,000 net acres. Complementary positions in the Eagle Ford create significant scale of approximately 65,000 net acres. Regarding capitalization, this business combination means liquidity to fund a drilling program through 2015 without accessing capital markets.

This week, Sabine Oil & Gas reported its Q1 2015 financial and operating results.  The results of operations of the Company presented for periods prior to the Forest Oil business combination on December 16, 2014 reflect the results and operations of the Company's accounting predecessor, Sabine Oil & Gas LLC.

Production volumes during Q1 of 2015 were 27.5 Bcfe, an increase of 10.9 Bcfe or 65 percent versus production of 16.6 Bcfe during Q1 of 2014. The increase in production is mainly because of the Forest Oil business combination completed in December 2014 and the Company's development program.

Revenues from production of oil, natural gas liquids, and natural gas decreased from $112.3 million in Q1 of 2014 to $97.6 million for Q1 of 2015, a decrease of 13 percent. The decrease of $14.7 million was because of a decline in average prices per Mcfe of 47 percent (before the effects of economic hedges), partly offset by an increase in production of 65 percent.

Sabine Oil & Gas Corp. (SOGC), closed Wednesday's trading session at $0.09, up 3.45%, on 788,327 volume with 52 trades. The average volume for the last 60 days is 1,370,458 and the stock's 52-week low/high is $0.0433/$2.59.

EFactor Group Corp. (EFCT)

SmallCapVoice, Investor News Source, AskSlapper, HEROSTOCKS, Stock Brain, WINNINGOTC, Wall Street Beauties, and FatCat Stocks reported on EFactor Group Corp. (EFCT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

EFactor Group Corp. is the owner of a group of entrepreneur-focused service companies. Additionally, the Company is the owner of EFactor.com, which is a social network providing content and resources for entrepreneurs worldwide. The EFactor network applies its proprietary selection and matching algorithm to offer specific content and resources. The design of these are to help entrepreneurs grow their businesses. EFactor Group has its head office in San Francisco, California.

The EFactor network has in excess of 1.5 million like-minded entrepreneurs. It connects entrepreneurs with the right people for their companies. It offers the tools, talent, and resources that assist entrepreneurs in succeeding. EFactor.com has members in 26 territories and 196 countries across 240 industries.

EFactor.com launched in March 2008. It provides online and face-to-face matching to relevant parties that can help grow a member’s business. These include investors, mentors, and peers to bring out and nurture contemporary new business ideas.

In addition, EFactor Group has a portfolio of companies to aid entrepreneurs based on their daily requirements. These are classified as the Company’s four divisions: Social Networking, Education and Mentoring, Business Services, and Funding. In essence, EFactor Group formed with the strategic goal of taking business owners through a complete value chain of resources and services that will considerably enhance their businesses’ chances of success.

EFactor Group announced in November 2014 the acquisition of Robson Dowry Associates, Ltd.  Robson Dowry will become part of EFactor Group's "Business Services" pillar through which this EFactor Group division provides business services to its entrepreneur members on EFactor.com. Robson Dowry is an independent branding and design group headquartered in the United Kingdom (UK).

Last month, EFactor Group announced the acquisition of RocketHub, Inc., a New York, New York based international funding platform. The expectation is that EFactor's acquisition of RocketHub will solidify the Company's funding division to provide education on funding approaches. This includes funding opportunities to its entrepreneur members on EFactor.com. RocketHub is considered one of America's largest crowdfunding platforms.

This week, EFactor announced that it will hold a conference call with investors and analysts. This will take place on Friday, May 15, 2015 at 9:00 a.m. ET. The Company will discuss its Q1 2015 financial results.

EFactor Group Corp. (EFCT), closed Wednesday's trading session at $0.085, up 25.00%, on 503,601 volume with 50 trades. The average volume for the last 60 days is 84,864 and the stock's 52-week low/high is $0.051/$1.00.

SolarWindow Technologies, Inc. (WNDW)

SmallCapVoice reported recently on SolarWindow Technologies, Inc. (WNDW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

SolarWindow Technologies, Inc. is a developer of next generation electricity-generating SolarWindow™ coatings. The Company was formerly known as New Energy Technologies, Inc. It changed its name to SolarWindow Technologies, Inc. this past March. The mission of SolarWindow Technologies has been to create SolarWindow™ products that generate considerable amounts of clean electricity, financially reward its customers, and benefit the environment. The Company has its headquarters in Columbia, Maryland.

SolarWindow™ systems can be installed on the readily-available sizeable window glass surfaces on tall towers and skyscrapers. SolarWindow™ can be applied to all four sides of tall towers, producing electricity using natural, shaded, and artificial light.

SolarWindow™ coatings generate electricity on see-through glass and flexible plastics with colored tints popular to skyscraper glass. SolarWindow™ uses organic materials that are dissolved into liquid, best for low-cost high-output manufacturing. SolarWindow™ is the subject of a patent pending technology.

Dr. Alastair Livesey, experimental physicist and technology developer, is one of the Company’s Founding Directors. He specialized in the commercialization of new energy breakthroughs at the world’s largest producer of flexible solar panels (2012).

In addition, SolarWindow Technologies’ commercial photovoltaic design and installation expert, Kelly Provence, is the U.S.’s first expert in his field to simultaneously hold four of the most coveted certifications from the North American Board of Certified Energy Practitioners and the Interstate Renewable Energy Council.

In essence, the Company’s SolarWindow™ products are undergoing development to be installed on all four sides of a skyscraper. This turns the entire building into a power generator. Commercial buildings account for 35 percent of all electricity consumed. Therefore, the Company believes this market opportunity is especially significant.

In April, SolarWindow Technologies announced that engineers and research scientists at the University of North Carolina Charlotte Energy Production and Infrastructure Center (UNCC-EPIC) independently reviewed and validated the Company’s SolarWindow™ proprietary Power Production and Financial Model. This Model calculates a financial payback of under one year for the Company’s transparent electricity-generating SolarWindow™ technology. To produce the equivalent amount of power with conventional solar systems would require a minimum of 5-11 years for payback and a minimum 10-12 acres of valuable urban land.

SolarWindow Technologies, Inc. (WNDW), closed Wednesday's trading session at $2.09, even for the day, on 30,738 volume with 52 trades. The average volume for the last 60 days is 60,871 and the stock's 52-week low/high is $1.10/$2.48.

NuGene International, Inc. (NUGN)

Today we are reporting on NuGene International, Inc. (NUGN), here at the QualityStocks Daily Newsletter.

NuGene International, Inc. specializes in developing, manufacturing, and marketing proprietary regenerative cosmeceutical and pharmaceutical products. These are based on adipose derived human stem cells and human stem cell media. The Company’s aim is to leverage its broad knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products, and also pharmaceutical products based on the same regenerative science platform. NuGene BioPharma, Inc. is the Company’s subsidiary. NuGene International is headquartered in Irvine, California.

The Company’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations. These are derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene’s exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations.

NuGene International has two patents pending covering 15 unique applications and inventions. Its products include its Skin Care Collection and its Hair Care Collection.

NuGene International entered into a License Agreement with kathy ireland Worldwide, Inc. in November 2014. NuGene licensed the right to use the trademarks and rights to the name, likeness, and visual representations of Kathy Ireland in connection with its cosmeceutical line of products containing adult human adipose stem cell derived or containing biologically active or biologically derived ingredients.

NuGene International recently announced that its subsidiary corporation, NuGene BioPharma acquired all rights, title and interest in and to SkinGuardian®, a Food and Drug Administration (FDA)-approved (monographed) skin protectant, antiseptic, and moisturizing topical cream. It acquired all intellectual property (IP) held by SkinGuardian and its Founder and Owner, Chris O'Brien, relating to the SkinGuardian technology and applications.

NuGene International has filed new patents to protect proprietary claims directed to bandages treated with Human Adipose Derived Stem Cell Cultured (HADSCC) media in an assortment of formats. This includes nanoencapsulated media dried to the dressings. Patent applications were filed for burn, scar and wound healing aids and bandages.

NuGene International, Inc. (NUGN), closed Wednesday's trading session at $2.63, up 1.15%, on 78,749 volume with 118 trades. The average volume for the last 60 days is 54,143 and the stock's 52-week low/high is $0.0086/$5.00.


The QualityStocks
Company Corner


International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0542, up 0.18%, on 557,646 volume with 37 trades. The stock’s average daily volume over the past 60 days is 882,398, and its 52-week low/high is $0.045/$0.1685.

International Stem Cell Corp. today provided a business update and announced first quarter financial results, including completion of the necessary preclinical studies for the company's Parkinson's program and formal submission of the application to begin the first clinical study of this novel approach to treating this debilitating disease in humans. Operating income from cosmeceutical and biomedical markets up 76% compared with the corresponding period of 2014 and the company posted $1.62 million in revenues for the three months ended March 31, 2015.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Announces 2015 First Quarter Results

International Stem Cell Corporation Publishes Results Demonstrating Treatment of Parkinson's Disease in Cell Transplantation

International Stem Cell Corporation Presents Data From Parkinson's Disease Program at AAN Annual Meeting

Loans4Less.com, Inc. (LFLS)

The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.20, up 100.00%, on 500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 4,475, and its 52-week low/high is $0.015/$0.20.

Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.

Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.

The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.

Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulted on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer

Loans4Less.com, Inc. Company Blog

Loans4Less.com, Inc. News:

LOANS4LESS.COM Enters into an Acquisition Agreement with 321LEND

Loans4Less.com, Inc. Enters into an Investment Banking Agreement with WestPark Capital, Inc. and Seeks Bank Strategic Partner for National Mortgage Broker Origination and Brand Exposure Opportunity

Loans4Less.com Seeks a Merger, Joint Venture Partner and/or Investor for National Loan Origination and Brand Exposure Opportunity

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.0675, up 16.38%, on 10,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 7,795, and its 52-week low/high is $0.032/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President

Cleartronic, Inc. (CLRI)

The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.155, up 3.33%, on 82,620 volume with 10 trades. The stock’s average daily volume over the past 60 days is 17,207, and its 52-week low/high is $0.04/$0.5499.

Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.

VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.

A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.

Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer

Cleartronic, Inc. Company Blog

Cleartronic, Inc. News:

Cleartronic, Inc. (CLRI) to Be Featured on National Radio Show And Web-TV

Cleartronic, Inc. (CLRI) Breaks 40 Million in Radio Transmissions as Both Customer Base and Transmissions Continue Rapid Growth

Cleartronic, Inc. (CLRI) Adds Shareholder Value With Cancellation of Two Billion Shares of Common Stock Held by CEO

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.055, up 10.00%, on 10,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 2,418 and its 52-week low/high is $0.05/$0.45.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview

Dominovas Energy Corp. Appoints International Business Professional to Board of Directors

Dominovas Energy and Delphi Sign MOU

Galenfeha, Inc. (GLFH)

The QualityStocks Daily Newsletter would like to spotlight Galenfeha, Inc. (GLFH). Today, Galenfeha, Inc. closed trading at $0.3498, up 2.88%, on 36,700 volume with 12 trades. The stock’s average daily volume over the past 60 days is 29,305, and its 52-week low/high is $0.1011/$4.00.

Galenfeha, Inc. (GLFH) is an engineering, product development, and manufacturing company that provides innovative solutions for oil and natural gas production, as well as stored energy products across a number of different industries. The company provides these products and services through its stored energy and oil & gas division.

Through its stored energy division, Galenfeha offers one of the most powerful, environmentally friendly battery systems in the market. The batteries have onboard computers, are inherently safe, internally temperature regulated, have optional GPS monitoring capabilities, offer significant weight reduction of up to 50%, and are engineered specifically for each type of application. Features include 100% “green” chemistry, RoHS compliancy, and active short circuit protection control.

Through its oil and gas division, the company offers chemical injection pumps that merge the perceived benefits of a hybrid, electric over pneumatic system. Galenfeha management believes the combination of the two parameter control systems represents a measurable shift in efficiency, reliability, cost management, and profitability to individual well locations as well as entire production fields. The combined technologies have demonstrated increased chemical injection accuracy, reducing chemical contamination in the production process while controlling cost and waste.

The company’s unwavering dedication is to continuously develop products that perform better than conventional solutions while also reducing environmental impact. Leveraging the management team’s wealth of resources and relationships, Galenfeha is well positioned for continued growth as the company aims to expand in both the stored energy and oil & gas industries. Disclaimer

Galenfeha, Inc. Company Blog

Galenfeha, Inc. News:

Galenfeha, Inc. Announces Engagement of QualityStocks Investor Relations Services

GALENFEHA, INC. Files SEC form 8-K, Change in Directors or Principal Officers

Galenfeha, Inc. Completes Field Testing, Begins Production and Shipping of New Battery System

IFAN Financial, Inc. (IFAN)

The QualityStocks Daily Newsletter would like to spotlight IFAN Financial, Inc. (IFAN). Today, IFAN Financial, Inc. closed trading at $0.101, off by 12.90%, on 1,302,109 volume with 97 trades. The stock’s average daily volume over the past 60 days is 22,597, and its 52-week low/high is $0.0114/$1.01.

IFAN Financial, Inc. (IFAN) and its wholly owned subsidiaries, iPIN Technologies and Mobicash America, are engaged in the design, development and distribution of software that enhances and enables mobile payments. The San Diego-based company has a growing portfolio of solutions, including the ability to use a debit card and corresponding PIN number while purchasing online via mobile phone, tablet, or computer and peer-to-peer cash transfers.

Keeping pace with the evolution of the information and communication (ICT) market, iPIN Technologies intends to provide a range of processing services for the industry’s future devices. The company is currently developing a new method of online selling through debit card payments and processing. iPIN technology attaches to any smartphone through the headphone jack and converts the device into a consumer PIN debit, same-as-cash payment solution. Using the iPIN Debit app, transactions are processed through the private and secure iPIN Technologies Network.

Mobicash America is an early-stage technology company that develops mobile payment solutions. The company’s platform product, Quidme, utilizes the text messaging function of a mobile phone, allowing the technology to operate on almost any phone or network, with or without data service. The functionality of the Quidme platform allows users to pay bills, purchase goods and services, and to send money to friends and relatives located locally or internationally via simple text message.

IFAN Financial continues to explore opportunities to expand its product portfolio to meet the growing demands for consumer/merchant convenience, speed and security within the mobile commerce market. Products in development will combine the functionality of social media, e-commerce and banking with the broader conveniences of the mobile environment. Disclaimer

IFAN Financial, Inc. Company Blog

IFAN Financial, Inc. News:

IFAN Financial, Inc. (IFAN) Expands Board of Directors With Addition of Technology Venture Veteran

IFAN Financial Applauds Facebook's Move Into the Mobile Payments Industry, Foresees Ancillary Opportunities

IFAN Financial Begins Beta Testing With Nation's Largest Debit Card Acquiring Processor


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters





INO.com Market Report



By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251